Trial NCT00603525

View at ClinicalTrials.gov 
Org. Study IDs: 110634
Secondary IDs: GEN411

Last trial update was posted on 2014-06-09

MeSH Interventions

Ofatumumab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions


Stopping Reasons

Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID